AEON Biopharma Inc (AEON): Dilution from the redemption of warrants...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: trglaa post# 15

Monday, 04/01/2024 2:38:13 PM

Monday, April 01, 2024 2:38:13 PM

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Keep Last Read

Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 08:27:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:07:43 PM
Form ARS/A - Annual Report to Security Holders: [Amend] • Edgar (US Regulatory) • 05/14/2024 01:15:36 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/14/2024 01:14:35 PM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/14/2024 01:05:41 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/23/2023 02:48:14 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 02:01:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:00:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 08:23:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 09:06:34 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 08/18/2023 09:27:03 PM
Strathspey Crown Holdings Group, LLC Provides Clarifying Statement Regarding Form 4 Filing with SEC for Holdings in AEON Biopharma • GlobeNewswire Inc. • 08/16/2023 11:00:00 AM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/12/2023 01:12:00 AM

InvestorsHub NewsWire

Only $200 per official company press release!